Isabelle Méar

MAPI Développement SAS engages in conceiving and implementing studies to evaluate drugs. It provides research and clinical trial services, risk management plan, direct patient management, signal detection, strategic consulting and linguistic validation. The company was founded by Bernard Jambon in 1974 and is headquartered in Lyon, France.

MAPI Développement SAS engages in conceiving and implementing studies to evaluate drugs. It provides research and clinical trial services, risk management plan, direct patient management, signal detection, strategic consulting and linguistic validation. The company was founded by Bernard Jambon in 1974 and is headquartered in Lyon, France.

MAPI Développement SAS engages in conceiving and implementing studies to evaluate drugs. It provides research and clinical trial services, risk management plan, direct patient management, signal detection, strategic consulting and linguistic validation. The company was founded by Bernard Jambon in 1974 and is headquartered in Lyon, France.

MAPI Développement SAS engages in conceiving and implementing studies to evaluate drugs. It provides research and clinical trial services, risk management plan, direct patient management, signal detection, strategic consulting and linguistic validation. The company was founded by Bernard Jambon in 1974 and is headquartered in Lyon, France.